Pharmaceutical associations back Amgen in appeal of US antitrust case brought by Sandoz
MLex Summary: Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization asked a US appeals court to reject Sandoz’s arguments to revive antitrust claims against Amgen over Enbrel. “Appellant’s position,...To view the full article, register now.
Already a subscriber? Click here to view full article